Immunic | VTL - Current Liabilities


Immunic reported $30.08M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Enanta Pharmaceuticals USD 44.73M 3.83M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Immunic USD 30.08M 2.77M Sep/2025
Insmed USD 468.87M 51.66M Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Quidel USD 966.1M 198.2M Dec/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025